Single Nucleotide Polymorphisms in TAOK3 Are Associated with High Opioid Requirement for Pain Management in Patients with Advanced Cancer Admitted to a Tertiary Palliative Care Unit.

Main|Search|PHGKB






Last Posted: Jul 26, 2018

---

• Single Nucleotide Polymorphisms in TAOK3 Are Associated with High Opioid Requirement for Pain Management in Patients with Advanced Cancer Admitted to a Tertiary Palliative Care Unit.
  Gutteridge Timothy et al. Journal of pain and symptom management 2018 Jul
• The Genomics of Neonatal Abstinence Syndrome.
  Cole F Sessions et al. Frontiers in pediatrics 2017 5176
• Effects of Single Nucleotide Polymorphisms on Surgical and Postsurgical Opioid Requirements: A Systematic Review and Meta-Analysis.
  Choi Siu-Wai et al. The Clinical journal of pain 2017 Dec 33(12) 1117-1130
• An Ambitious Research Plan to Help Solve the Opioid Crisis 
• The impact of OPRM1's genetic polymorphisms on methadone maintenance treatment in opioid addicts: a systematic review.
  Oueslati Bilel et al. Pharmacogenomics 2018 May
• Confronting the Opioid Epidemic 
• Pharmacogenetics of Opioid Use Disorder Treatment.
  Crist Richard C et al. CNS drugs 2018 Apr
• NIH launches HEAL Initiative, doubles funding to accelerate scientific solutions to stem national opioid epidemic
  NIH News Release, Apr 4, 2018
• Pharmacogenomics and Patient Treatment Parameters to Opioid Treatment in Chronic Pain: A Focus on Morphine, Oxycodone, Tramadol, and Fentanyl.
  Lloyd Renae A et al. Pain medicine (Malden, Mass.) 2017 Dec 18(12) 2369-2387
• CYP2D6 Pharmacogenetics Testing and Post-Cesarean Section Pain Scores-a Preliminary Study.
  Ribeiro Carolina et al. Pain medicine (Malden, Mass.) 2018 Mar

more